Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26556407 | 0.91 | BBOX1 (0.37) | TSHRPPARDBBOX1CA2LPAR1 | |
| Diethyl Hydrogen Phosphate SCHEMBL28306776 | 0.85 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL11406073 | 0.85 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL27267327 | 0.85 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL93056 | 0.83 | — | — | |
| Diethyl Hydrogen Phosphate SCHEMBL27294237 | 0.83 | TSHR (0.56) | TSHRPPARDTP53TDP1CA12 | |
| SCHEMBL19293677 | 0.80 | BBOX1 (0.31) | BBOX1 | |
| Diethyl Hydrogen Phosphate SCHEMBL3133022 | 0.80 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL906759 | 0.80 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL4948463 | 0.80 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8269031-B2 | Phosphorylcholine group-containing compound, method of manufacturing a phosphorylcholine group-containing compound, surface-modifying agent, and a method of modifying a surface using a surface-modifying agent | SHISEIDO COMPANY, LTD. (JP) | 2012-09-18 | — | — | US | disclosed |
| US-8222442-B2 | Phosphorylcholine group-containing compound, method of manufacturing a phosphorylcholine group-containing compound, surface-modifying agent, and a method of modifying a surface using a surface-modifying agent | SHISEIDO COMPANY, LTD. (JP) | 2012-07-17 | — | — | US | disclosed |
| US-8222443-B2 | Phosphorylcholine group-containing compound, method of manufacturing a phosphorylcholine group-containing compound, surface-modifying agent, and a method of modifying a surface using a surface-modifying agent | SHISEIDO COMPANY, LTD. (JP) | 2012-07-17 | — | — | US | disclosed |
| US-8187623-B2 | Medical copolymers | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20120059183-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20120046489-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | SHISEIDO COMPANY, LTD. | 2012-02-23 | — | — | US | disclosed |
| US-20110217783-A1 | CLEAVABLE SURFACTANTS AND METHODS OF USE THEREOF | VANDERBILT UNIVERSITY | 2011-09-08 | — | — | US | disclosed |
| US-20100113817-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20090324679-A1 | MEDICAL COPOLYMERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110217783-A1 | CLEAVABLE SURFACTANTS AND METHODS OF USE THEREOF | PHOSPHO1, SGMS1, SGMS2 | TSHR 2737/4885PPARD 2793/4885TP53 403/4885 |
| US-20120059183-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | PHOSPHO1, SGMS1, SGMS2 | TSHR 3564/4885PPARD 4274/4885TP53 4795/4885 |
| US-20100113817-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | PHOSPHO1, SGMS1, SGMS2 | TSHR 3564/4885PPARD 4274/4885TP53 4795/4885 |
| US-20090324679-A1 | MEDICAL COPOLYMERS | CCR9, CTR9, F9 | TSHR 2934/4885PPARD 2412/4885TP53 986/4885 |
| US-20120046489-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | PHOSPHO1, SGMS1, SGMS2 | TSHR 3564/4885PPARD 4274/4885TP53 4795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.